Sandur Manganese Enters Medical Devices Business

The Sandur Manganese & Iron Ores Limited has incorporated Royal Sandur MedTech Private Limited as its wholly owned subsidiary, marking its entry into the medical devices and healthcare consumables manufacturing space. The subsidiary was incorporated in India on September 25, 2026, following the Certificate of Incorporation issued by the Ministry of Corporate Affairs. Royal Sandur MedTech will operate in the medical devices and consumables manufacturing industry. Its proposed business includes manufacturing, processing, assembling, marketing and distribution of medical devices, surgical products, diagnostic products and healthcare consumables. This gives Sandur Manganese exposure to a new business segment beyond its existing operations. The subsidiary is fully owned by The Sandur Manganese & Iron Ores Limited, with 100% of its shareholding held by the listed company. Sandur Manganese has subscribed to 10,00,000 equity shares of ₹10 each, involving a total cash investment of ₹1 crore. The incorporation provides Sandur Manganese with a dedicated platform to develop and participate in the medical products ecosystem. The company has not disclosed, in the filing, details regarding the proposed manufacturing facility, production capacity, specific products to be launched, commercial commencement date or expected revenue contribution from the new subsidiary. For investors, the key factors to monitor going forward will include capital deployment, regulatory requirements applicable to medical devices and diagnostics, manufacturing setup, product launches and the pace of commercialisation. The eventual contribution of Royal Sandur MedTech to the consolidated business will depend on execution and market adoption. The development marks a strategic diversification for Sandur Manganese & Iron Ores, with the company now establishing a presence in medical devices, surgical products, diagnostics and healthcare consumables alongside its existing business operations.